Advanced search
Publication Cover
Research and Reports in Urology Volume 15, 2023 - Issue
Submit an article Journal homepage
370
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Focal Irreversible Electroporation for Localized Prostate Cancer – Oncological and Safety Outcomes Using mpMRI and Transperineal Biopsy Follow-Up

Ilan Gielchinsky1 Research Branch, Meuhedet Health Services, Tel-Aviv, Israel;2 Department of Urology, Assaf Harofeh Medical Center, Tzrifin, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8337-9404View further author information
ORCID Icon &
Naama Lev-Cohain3 Department of Radiology, Hadassah Medical Center, Jerusalem, IsraelView further author information
Pages 27-35 | Received 03 Nov 2022, Accepted 18 Jan 2023, Published online: 22 Jan 2023

References

  • Blazevski A, Scheltema MJ, Amin A, Thompson JE, Lawrentschuk N, Stricker PD. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment. BJU Int. 2020;125(3):369–378. doi:10.1111/bju.14951
  • Scheltema MJ, Chang JI, van den Bos W, et al. Preliminary diagnostic accuracy of multiparametric magnetic resonance imaging to detect residual prostate cancer following focal therapy with irreversible electroporation. Eur Urol Focus. 2017;5(4):585–591.
  • Guenther E, Klein N, Zapf S, et al. Prostate cancer treatment with Irreversible Electroporation (IRE): safety, efficacy and clinical experience in 471 treatments. PLoS One. 2019;14(4):e0215093. doi:10.1371/journal.pone.0215093
  • van den Bos W, Scheltema MJ, Siriwardana AR, et al. Focal irreversible electroporation as primary treatment for localized prostate cancer. BJU Int. 2018;121(5):716–724. doi:10.1111/bju.13983
  • Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361. doi:10.1101/cshperspect.a030361
  • Enikeev D, Taratkin M, Morozov A, et al. Focal irreversible electroporation for localized prostate cancer management: prospective assessment of efficacy and safety. Minerva Urol E Nefrol Ital J Urol Nephrol. 2020;72(5):644–645.
  • Blazevski A, Scheltema MJ, Yuen B, et al. Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort. Eur Urol Oncol. 2020;3(3):283–290. doi:10.1016/j.euo.2019.04.008
  • Morozov A, Taratkin M, Barret E, et al. A systematic review of irreversible electroporation in localised prostate cancer treatment. Andrologia. 2020;52(10):e13789. doi:10.1111/and.13789
  • Scheltema MJ, van den Bos W, Siriwardana AR, et al. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer. BJU Int. 2017;120:51–58. doi:10.1111/bju.13991

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.